Could a Copper-Binding drug shrink thickened heart muscle?

NCT ID NCT04706429

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested whether the drug trientine can reduce heart muscle thickening and improve exercise ability in people with hypertrophic cardiomyopathy (HCM), a condition where the heart muscle becomes abnormally thick. 154 adults with HCM took either trientine or a placebo for 12 months. The main goal was to see if the drug could shrink the heart muscle and improve heart function.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTROPHIC CARDIOMYOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertrophic cardiomyopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Liverpool Heart and Chester Hospital NHS Foundation Trust

    Liverpool, L14 3PE, United Kingdom

  • Manchester University NHS Foundation Trust

    Manchester, M23 9LT, United Kingdom

  • NHS Grampian

    Aberdeen, AB25 2ZN, United Kingdom

  • Northumbria Healthcare NHS Foundation Trust

    North Shields, NE29 8NH, United Kingdom

  • Oxford University Hospitals NHS Foundation Trust

    Oxford, OX3 9DU, United Kingdom

  • Royal Brompton and Harefield NHS Foundation Trust

    London, SW3 6NP, United Kingdom

  • University Hospitals of Leicester NHS Foundation Trust

    Leicester, LE3 9QP, United Kingdom